Widely used:Recently Viewed
Clear All
Value Research Rating
Quality Score 
8/10
Growth Score
6/10
Valuation Score
3/10
Momentum Score
5/10
₹22,598 Cr
35.87
4.56
42.1
0
13.56 %
--
0.96 %
251.95
32
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Alembic Pharma
| 51.42 | -4.83 | 16.55 | 43.57 | 12.55 | 16.52 | 11.15 |
|
BSE Healthcare
| 41.84 | 0.99 | 16.54 | 58.12 | 19.17 | 29.56 | 12.67 |
|
BSE Mid Cap
| 32.18 | -1.12 | 2.50 | 50.73 | 22.18 | 28.61 | 17.79 |
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
|
|---|---|---|---|---|---|---|---|
|
Alembic Pharma
| 32.55 | -28.56 | -23.09 | 87.72 | -2.65 | 12.90 | -10.84 |
|
BSE Mid Cap
| 45.53 | 1.38 | 39.18 | 19.87 | -3.05 | -13.31 | 48.13 |
|
BSE Healthcare
| 36.97 | -12.10 | 20.87 | 61.45 | -3.55 | -5.89 | 0.49 |
|
Stock
|
Peer Median
|
||
|---|---|---|---|
loading... |
|||
|
Stock
|
Peer Median
|
||
|---|---|---|---|
loading... |
|||
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Our rating system has guided millions of investors in the past 20 years.
₹22,597.88 Cr
₹6,304.21 Cr
₹629.93 Cr
₹126.57 Cr
₹430.45 Cr
69.61%
High
₹707.15 - 1,303.90
₹2.00
19,65,63,124
BSE: 533573, NSE: APLLTD
Vadodara, Gujarat
www.alembicpharmaceuticals.com
Alembic Pharmaceuticals Limited develops, manufactures, and markets pharmaceutical products in India and internationally. The company provides branded specialty medicines in various therapeutic areas, such as cardiology, gynecology, gastrology,... ophthalmology, dermatology, nephrology/urology, orthopedics, anti-infective, cold and cough, veterinary, and anti-diabetic; generics formulations in oral solids, oncology oral solids and injectables, general injectables and ophthalmic products, dermatology, and oral suspension; and active pharmaceutical ingredients. It also exports its products. The company was founded in 1907 and is headquartered in Vadodara, India. Read more
The total asset value of Alembic Pharmaceuticals Ltd stood at ₹ 6,446 Cr as on 30-Jun-24
The share price of Alembic Pharmaceuticals Ltd is ₹1,149.85 (NSE) and ₹1,149.65 (BSE) as of 15-Oct-2024 IST. Alembic Pharmaceuticals Ltd has given a return of 12.55% in the last 3 years.
Alembic Pharmaceuticals Ltd has a market capitalisation of ₹ 22,598 Cr as on 15-Oct-2024. As per Value Research classification, it is a Mid Cap company.
The P/B ratio of Alembic Pharmaceuticals Ltd is 4.56 times as on 15-Oct-2024, a 7% discount to its peers’ median range of 4.91 times.
The P/E ratio of Alembic Pharmaceuticals Ltd is 35.87 times as on 15-Oct-2024, a 15% discount to its peers’ median range of 42.10 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Alembic Pharmaceuticals Ltd and enter the required number of quantities and click on buy to purchase the shares of Alembic Pharmaceuticals Ltd.
Alembic Pharmaceuticals Limited develops, manufactures, and markets pharmaceutical products in India and internationally. The company provides branded specialty medicines in various therapeutic areas, such as cardiology, gynecology, gastrology, ophthalmology, dermatology, nephrology/urology, orthopedics, anti-infective, cold and cough, veterinary, and anti-diabetic; generics formulations in oral solids, oncology oral solids and injectables, general injectables and ophthalmic products, dermatology, and oral suspension; and active pharmaceutical ingredients. It also exports its products. The company was founded in 1907 and is headquartered in Vadodara, India.
The prominent promoters of Alembic Pharmaceuticals Ltd. are
| Name of promoters | Holding percentage |
|---|---|
|
Nirayu Limited |
35.63%
|
|
Alembic Limited |
28.54%
|
|
Chirayu Ramanbhai Amin |
2.13%
|
The chairman of the company is Chirayu Amin, and the managing director is Shaunak Amin.
There is no promoter pledging in Alembic Pharmaceuticals Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
50,601
|
|
|
35,421
|
|
|
30,524
|
|
|
29,359
|
| Alembic Pharmaceuticals Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
13.56
|
|
Operating margin(%)
|
11.04
|
|
Net Margin(%)
|
9.97
|
|
Dividend yield(%)
|
0.96
|
Yes, TTM profit after tax of Alembic Pharmaceuticals Ltd was ₹630 Cr.
₹23.35
